Allosteric PI3Kα Inhibition Overcomes On-target Resistance to Orthosteric Inhibitors Mediated by Secondary PIK3CA MutationsAndreas VarkarisFerran Fece de la Cruzet al.2023Cancer Discovery
Parallel genomic alterations of antigen and payload targets mediate polyclonal acquired clinical resistance to sacituzumab govitecan in triple-negative breast cancerJames T. CoatesSheng Sunet al.2021Cancer Discovery